3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Recurrence
3
Esophageal Squamous Cell Carcinoma
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
2
Tuberous Sclerosis
1
Solid Tumors
1
Refractory or Relapsed Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Itraconazole
×
1 year
×
Clear all
No trials found.